ViƱa, Analyn T.
HRN: 21-41-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2022
METRONIDAZOLE 500MG (TAB)
05/31/2022
06/07/2022
IVT
500mg/tab
TID
Post NSVD; Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes